MedPath

Comparative study of the effect of fluoxetine and gabapentin in diabetic foot patients

Phase 3
Conditions
Diabetic foot ulcer.
Non-pressure chronic ulcer of thigh
L97.1
Registration Number
IRCT20200324046850N4
Lead Sponsor
Abadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Inclusion criteria are: at least one year past diagnosis of diabetes, symptoms of neuropathy and tendency to participate in the study, as well as diabetic foot patients with grade 1 (superficial ulcer) and grade 2 (deep tendon ulcer or articular capsule) will be included in the study

Exclusion Criteria

Cases such as patients with concomitant cardiovascular disease, noncompliance with medication and trials, and diabetic foot patients with grade 3 or more ulcer are excluded.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of pain. Timepoint: On the first days, 15 and 30 examinations. Method of measurement: Pain assessment is done on the first, 15th, and 30th days after intervention based on the VAS index, both verbally and visually.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath